$CHD
CHURCH & DWIGHT CO INC /DE/

2016 Q4 Form 10-Q Financial Statement

#000156459016027241 Filed on November 03, 2016

View on sec.gov

Income Statement

Concept 2016 Q4 2016 Q3 2015 Q3
Revenue $896.0M $870.7M $861.8M
YoY Change 2.56% 1.03% 2.38%
Cost Of Revenue $488.0M $475.1M $476.0M
YoY Change 2.48% -0.19% 0.36%
Gross Profit $408.0M $395.6M $385.8M
YoY Change 2.67% 2.54% 4.98%
Gross Profit Margin 45.54% 45.43% 44.77%
Selling, General & Admin $234.6M $199.6M $194.2M
YoY Change 2.99% 2.78% 2.1%
% of Gross Profit 57.5% 50.46% 50.34%
Research & Development $14.50M $16.00M
YoY Change -9.38% 8.11%
% of Gross Profit 3.67% 4.15%
Depreciation & Amortization $27.40M $14.30M $14.50M
YoY Change 10.93% -1.38% 4.32%
% of Gross Profit 6.72% 3.61% 3.76%
Operating Expenses $234.6M $14.50M $16.00M
YoY Change 2.99% -9.38% 8.11%
Operating Profit $173.4M $196.0M $190.6M
YoY Change 2.48% 2.83% 7.56%
Interest Expense -$3.900M -$3.900M $7.400M
YoY Change -23.53% -152.7% 7.25%
% of Operating Profit -2.25% -1.99% 3.88%
Other Income/Expense, Net $0.00 $300.0K -$800.0K
YoY Change -100.0% -137.5% -27.27%
Pretax Income $169.5M $192.4M $185.7M
YoY Change 2.79% 3.61% 7.22%
Income Tax $59.10M $68.40M $65.30M
% Of Pretax Income 34.87% 35.55% 35.16%
Net Earnings $110.4M $124.0M $120.4M
YoY Change 1.19% 2.99% 3.88%
Net Earnings / Revenue 12.32% 14.24% 13.97%
Basic Earnings Per Share $0.43 $0.48 $0.46
Diluted Earnings Per Share $0.42 $0.47 $0.45
COMMON SHARES
Basic Shares Outstanding 258.6M 131.1M
Diluted Shares Outstanding 133.6M

Balance Sheet

Concept 2016 Q4 2016 Q3 2015 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $187.8M $232.1M $212.9M
YoY Change -43.4% 9.02% -42.49%
Cash & Equivalents $187.8M $232.1M $210.6M
Short-Term Investments $2.300M
Other Short-Term Assets $23.80M $21.40M $21.80M
YoY Change -7.75% -1.83% -45.09%
Inventory $258.2M $285.7M $274.3M
Prepaid Expenses
Receivables $287.0M $265.3M $330.7M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $756.8M $804.5M $851.7M
YoY Change -16.47% -5.54% -14.21%
LONG-TERM ASSETS
Property, Plant & Equipment $588.6M $592.7M $610.0M
YoY Change -3.44% -2.84% 2.38%
Goodwill $1.444B $1.354B
YoY Change 6.58%
Intangibles $1.432B $1.280B
YoY Change 12.78%
Long-Term Investments $8.500M $8.000M $7.900M
YoY Change 1.19% 1.27% -68.15%
Other Assets $124.3M $118.2M $114.4M
YoY Change 14.56% 3.32% 9.68%
Total Long-Term Assets $3.597B $3.478B $3.366B
YoY Change 7.35% 3.33% 0.99%
TOTAL ASSETS
Total Short-Term Assets $756.8M $804.5M $851.7M
Total Long-Term Assets $3.597B $3.478B $3.366B
Total Assets $4.354B $4.283B $4.218B
YoY Change 2.28% 1.54% -2.5%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $331.6M $319.6M $283.2M
YoY Change 12.83% 12.85% 1.8%
Accrued Expenses $237.3M $225.5M $200.4M
YoY Change 11.72% 12.52% -10.58%
Deferred Revenue
YoY Change
Short-Term Debt $426.8M $230.6M $25.00M
YoY Change 19.48% 822.4% -93.81%
Long-Term Debt Due $250.0M
YoY Change
Total Short-Term Liabilities $1.002B $785.8M $783.0M
YoY Change 14.8% 0.36% -14.74%
LONG-TERM LIABILITIES
Long-Term Debt $693.4M $699.1M $706.0M
YoY Change 0.09% -0.98% 8.68%
Other Long-Term Liabilities $168.7M $170.2M $157.0M
YoY Change 6.57% 8.41% 0.77%
Total Long-Term Liabilities $862.1M $869.3M $863.0M
YoY Change 1.29% 0.73% 7.15%
TOTAL LIABILITIES
Total Short-Term Liabilities $1.002B $785.8M $783.0M
Total Long-Term Liabilities $862.1M $869.3M $863.0M
Total Liabilities $2.376B $2.163B $2.168B
YoY Change 6.38% -0.25% -3.14%
SHAREHOLDERS EQUITY
Retained Earnings $2.926B $2.861B $2.585B
YoY Change 10.42% 10.69% 10.0%
Common Stock $544.2M $541.6M $520.5M
YoY Change 4.09% 4.05% 255.53%
Preferred Stock
YoY Change
Treasury Stock (at cost) $1.429B $1.231B $1.011B
YoY Change 29.43% 21.78% 33.28%
Treasury Stock Shares $38.89M $34.50M $15.43M
Shareholders Equity $1.978B $2.120B $2.050B
YoY Change
Total Liabilities & Shareholders Equity $4.354B $4.283B $4.218B
YoY Change 2.28% 1.54% -2.5%

Cashflow Statement

Concept 2016 Q4 2016 Q3 2015 Q3
OPERATING ACTIVITIES
Net Income $110.4M $124.0M $120.4M
YoY Change 1.19% 2.99% 3.88%
Depreciation, Depletion And Amortization $27.40M $14.30M $14.50M
YoY Change 10.93% -1.38% 4.32%
Cash From Operating Activities $160.3M $198.5M $160.4M
YoY Change -18.75% 23.75% -20.55%
INVESTING ACTIVITIES
Capital Expenditures -$21.70M -$10.30M -$10.70M
YoY Change 26.9% -3.74% -43.98%
Acquisitions
YoY Change
Other Investing Activities -$130.1M $1.100M -$1.000M
YoY Change 8573.33% -210.0% -99.54%
Cash From Investing Activities -$151.8M -$9.200M -$11.70M
YoY Change 716.13% -21.37% -95.03%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities -46.90M -167.1M -132.4M
YoY Change -14.26% 26.21% -160.54%
NET CHANGE
Cash From Operating Activities 160.3M 198.5M 160.4M
Cash From Investing Activities -151.8M -9.200M -11.70M
Cash From Financing Activities -46.90M -167.1M -132.4M
Net Change In Cash -38.40M 22.20M 16.30M
YoY Change -130.97% 36.2% -91.19%
FREE CASH FLOW
Cash From Operating Activities $160.3M $198.5M $160.4M
Capital Expenditures -$21.70M -$10.30M -$10.70M
Free Cash Flow $182.0M $208.8M $171.1M
YoY Change -15.11% 22.03% -22.58%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2016Q4 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
258603709
CY2016Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
14500000
us-gaap Common Stock Dividends Per Share Cash Paid
CommonStockDividendsPerShareCashPaid
0.51
CY2015Q4 us-gaap Inventory Net
InventoryNet
274000000
CY2015Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
330000000
us-gaap Other Comprehensive Income Loss Derivatives Qualifying As Hedges Net Of Tax
OtherComprehensiveIncomeLossDerivativesQualifyingAsHedgesNetOfTax
3700000
CY2015Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
276200000
CY2015Q4 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1000000
us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
1200000
us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
169200000
us-gaap Profit Loss
ProfitLoss
301300000
us-gaap Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentNetOfTax
-3900000
us-gaap Operating Income Loss
OperatingIncomeLoss
505000000
us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
-8400000
us-gaap Earnings Per Share Basic
EarningsPerShareBasic
1.15
us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
312000000
us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-10200000
us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4400000
us-gaap Interest Expense
InterestExpense
22900000
us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
470500000
us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
262600000
us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
267600000
us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
291100000
us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
1.13
us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-17800000
CY2015Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000
CY2015Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
292855100
CY2015Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4256900000
CY2015Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2015Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
230000000
CY2015Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2015Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2015Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
CY2015Q4 us-gaap Treasury Stock Shares
TreasuryStockShares
32947012
CY2016Q3 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
292855100
CY2015Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2023200000
CY2016Q3 us-gaap Treasury Stock Shares
TreasuryStockShares
34496480
us-gaap Depreciation
Depreciation
45000000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
35200000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
19800000
chd Income Loss From Equity Method Investments Excluding Impairment Charges
IncomeLossFromEquityMethodInvestmentsExcludingImpairmentCharges
6700000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
7100000
us-gaap Pension Expense
PensionExpense
8400000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-127100000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
48000000
CY2016Q3 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2016Q3 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2016Q3 us-gaap Common Stock Value
CommonStockValue
292800000
CY2016Q3 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
248800000
CY2016Q3 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
2861200000
CY2016Q3 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-51800000
CY2016Q3 us-gaap Treasury Stock Value
TreasuryStockValue
1231000000
CY2016Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2120000000
CY2016Q3 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
4282700000
CY2016Q3 us-gaap Allowance For Doubtful Accounts Receivable Current
AllowanceForDoubtfulAccountsReceivableCurrent
1800000
CY2016Q3 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
1.00
CY2016Q3 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
2500000
CY2016Q3 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2016Q3 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
1.00
us-gaap Pension Expense
PensionExpense
0
us-gaap Increase Decrease In Other Operating Capital Net
IncreaseDecreaseInOtherOperatingCapitalNet
1700000
CY2016Q3 us-gaap Pension And Other Postretirement Defined Benefit Plans Liabilities Noncurrent
PensionAndOtherPostretirementDefinedBenefitPlansLiabilitiesNoncurrent
25200000
CY2016Q3 us-gaap Liabilities
Liabilities
2162700000
CY2016Q3 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
us-gaap Depreciation
Depreciation
44100000
us-gaap Adjustment For Amortization
AdjustmentForAmortization
32200000
us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
20400000
chd Income Loss From Equity Method Investments Excluding Impairment Charges
IncomeLossFromEquityMethodInvestmentsExcludingImpairmentCharges
9000000
us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
9800000
us-gaap Share Based Compensation
ShareBasedCompensation
14100000
us-gaap Asset Impairment Charges
AssetImpairmentCharges
800000
us-gaap Other Noncash Income Expense
OtherNoncashIncomeExpense
-300000
us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-13200000
us-gaap Increase Decrease In Inventories
IncreaseDecreaseInInventories
6500000
us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
-3000000
us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
18800000
us-gaap Increase Decrease In Accrued Income Taxes Payable
IncreaseDecreaseInAccruedIncomeTaxesPayable
33400000
us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
29400000
us-gaap Proceeds From Repayments Of Short Term Debt
ProceedsFromRepaymentsOfShortTermDebt
-121700000
us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
23300000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
29400000
us-gaap Excess Tax Benefit From Share Based Compensation Financing Activities
ExcessTaxBenefitFromShareBasedCompensationFinancingActivities
13600000
us-gaap Payments Of Dividends
PaymentsOfDividends
137400000
us-gaap Payments Of Dividends
PaymentsOfDividends
131400000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
200000000
us-gaap Payments For Repurchase Of Common Stock
PaymentsForRepurchaseOfCommonStock
263100000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-5600000
us-gaap Proceeds From Payments For Other Financing Activities
ProceedsFromPaymentsForOtherFinancingActivities
-1000000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-392700000
us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
-480300000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
2600000
us-gaap Effect Of Exchange Rate On Cash And Cash Equivalents
EffectOfExchangeRateOnCashAndCashEquivalents
-18300000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-97900000
us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
-212400000
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
423000000
CY2015Q3 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
210600000
us-gaap Interest Paid Net
InterestPaidNet
15100000
CY2015Q4 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
84600000
CY2016Q3 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
30600000
CY2015Q4 us-gaap Inventory Work In Process Net Of Reserves
InventoryWorkInProcessNetOfReserves
33100000
CY2016Q3 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
182700000
CY2015Q4 us-gaap Inventory Finished Goods Net Of Reserves
InventoryFinishedGoodsNetOfReserves
156300000
CY2015Q3 us-gaap Depreciation
Depreciation
14500000
CY2016Q3 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1172400000
CY2015Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
1145000000
CY2016Q3 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
579700000
CY2015Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
535400000
CY2016Q3 us-gaap Depreciation
Depreciation
14300000
us-gaap Interest Paid Net
InterestPaidNet
15800000
us-gaap Income Taxes Paid
IncomeTaxesPaid
134700000
us-gaap Income Taxes Paid
IncomeTaxesPaid
110700000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
7500000
us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
5500000
CY2014Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2101900000
us-gaap Dividends Cash
DividendsCash
131400000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
263100000
chd Accelerated Share Repurchases Settlement Value Payment Or Receipt
AcceleratedShareRepurchasesSettlementValuePaymentOrReceipt
0
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
51100000
CY2015Q3 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
2049600000
us-gaap Dividends Cash
DividendsCash
137400000
us-gaap Treasury Stock Value Acquired Cost Method
TreasuryStockValueAcquiredCostMethod
200000000
us-gaap Stock Issued During Period Value Share Based Compensation
StockIssuedDuringPeriodValueShareBasedCompensation
91500000
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
13600000
us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
29400000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.170
CY2015Q3 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
16000000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
45000000
us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
48100000
CY2016Q3 us-gaap Inventory Raw Materials And Supplies Net Of Reserves
InventoryRawMaterialsAndSuppliesNetOfReserves
72400000
CY2016Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
2
CY2016Q3 chd Percentage Of Stock Dividend Payable On Stock Split Of Common Stock
PercentageOfStockDividendPayableOnStockSplitOfCommonStock
1.00
us-gaap Dividend Payable Date To Be Paid Day Month And Year
DividendPayableDateToBePaidDayMonthAndYear
2016-09-01
us-gaap Dividends Payable Date Of Record Day Month And Year
DividendsPayableDateOfRecordDayMonthAndYear
2016-08-15
CY2016Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4700000
CY2015Q3 us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5000000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
4700000
us-gaap Weighted Average Number Diluted Shares Outstanding Adjustment
WeightedAverageNumberDilutedSharesOutstandingAdjustment
5000000
CY2016Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1300000
CY2015Q3 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
1000000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2000000
us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
2200000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2000000
us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
2800000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
300000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
16100000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
9800000
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
46.75
us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
16.68
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
38.84
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
29.99
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
22.90
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P6Y
us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P4Y7M6D
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
291000000
CY2016Q3 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
245000000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
34100000
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
9400000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
89400000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
41700000
CY2016Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1600000
CY2015Q3 us-gaap Stock Option Plan Expense
StockOptionPlanExpense
1700000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
12800000
us-gaap Stock Option Plan Expense
StockOptionPlanExpense
13100000
CY2016Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
2200000
CY2015Q3 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
0.0
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
7.58
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
6.87
CY2015Q3 us-gaap Stock Issued1
StockIssued1
0
us-gaap Stock Issued1
StockIssued1
15400000
us-gaap Stock Issued1
StockIssued1
14800000
us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.020

Files In Submission

Name View Source Status
0001564590-16-027241-index-headers.html Edgar Link pending
0001564590-16-027241-index.html Edgar Link pending
0001564590-16-027241.txt Edgar Link pending
0001564590-16-027241-xbrl.zip Edgar Link pending
chd-10q_20160930.htm Edgar Link pending
chd-20160930.xml Edgar Link completed
chd-20160930.xsd Edgar Link pending
chd-20160930_cal.xml Edgar Link unprocessable
chd-20160930_def.xml Edgar Link unprocessable
chd-20160930_lab.xml Edgar Link unprocessable
chd-20160930_pre.xml Edgar Link unprocessable
chd-ex311_6.htm Edgar Link pending
chd-ex312_7.htm Edgar Link pending
chd-ex321_8.htm Edgar Link pending
chd-ex322_9.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
g2016110315155469910289.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending